1. Articles in category: News

    121-144 of 185 « 1 2 3 4 5 6 7 8 »
    1. CHOP Invited to White House for President's Announcement of the Precision Medicine Initiative

      CHOP Invited to White House for President's Announcement of the Precision Medicine Initiative

      "The Precision Medicine Initiative, which President Obama first announced in his 2015 State of the Union speech, calls for new funding to build a national infrastructure to help sophisticated biomedical data flow from health clinics to DNA sequencing labs and back again as innovative treatments. The National Institutes of Health, Food and Drug Administration, and the Office of National Coordination for Health Information Technology will be involved in this program, which would allow researchers to custom-design more effective therapies based on a patient's individual genetic profile."

      Read Full Article
    2. 'Off switch' for pain discovered: Activating the adenosine A3 receptor subtype is key to powerful pain relief

      'Off switch' for pain discovered: Activating the adenosine A3 receptor subtype is key to powerful pain relief

      "It has long been appreciated that harnessing the potent pain-killing effects of adenosine could provide a breakthrough step towards an effective treatment for chronic pain," Salvemini said. "Our findings suggest that this goal may be achieved by focusing future work on the A3AR pathway, in particular, as its activation provides robust pain reduction across several types of pain."

      Read Full Article
    3. New ICR chief's three-pronged attack on cancer

      New ICR chief's three-pronged attack on cancer

      "Paul Workman, the new chief executive of the Institute of Cancer Research in London  has pledged to attack the disease’s ability to evolve and evade treatment.  Prof Workman, who had been interim CEO since July, says he plans to embed the ICR’s recently-established Centre for Evolution and Cancer and innovative research projects in cancer biology and the disease's survival networks in an integrated programme “aimed at overcoming the scourge of treatment resistance”. He speaks about three priorities in drug discovery, the first being “expanding the druggable cancer genome”.

      Read Full Article
    4. Five ways that NICE could help bring innovative cancer medicines into the NHS

      Five ways that NICE could help bring innovative cancer medicines into the NHS

      21 Oct 2014 Posted on 21 October, 2014 by Professor Paul Workman Like on Facebook Tweet on Twitter Share on Google Plus Share on LinkedIn

      Earlier this year, NICE released complex and far-reaching set of proposals for redrawing how it evaluates drugs for use on the NHS. The process NICE uses has been the subject of intense debate for many years, and I certainly agree that reform is very much needed.

      Read Full Article
    5. Saatchi untested drugs for dying bill gets govt support

      Saatchi untested drugs for dying bill gets govt support

      Saatchi untested drugs for dying bill gets govt support.

      The Medical Innovation Bill was proposed by former advertising guru Lord Saatchi, who lost his wife to cancer in 2011. Its premise is to seek clarification in law that it would not be negligent for a doctor to deviate from standard practice in treating a serious or life-threatening condition if the decision to do so is taken responsibly and is in the patient's best interest.

      Read Full Article
    6. European Commission misses a chance to open a pipeline of cancer drugs to children

      European Commission misses a chance to open a pipeline of cancer drugs to children

      "It’s the final point here which causes the problems.  We certainly wouldn’t want companies to be obliged to trial drugs in children when they are likely to be ineffective or unsafe, but judging whether a treatment is likely to work by where in the body a tumour is located is outdated. Medicine has moved on from simply categorising cancers as ‘breast cancer’ or ‘lung cancer’ - we can now look at specific molecular defects in an individual’s cancer, and use medicines specifically targeted at genetic features of that tumour. These genetic features may occur in a subset of ...

      Read Full Article
    7. Hormone that keeps us alert also suppresses the spread of cancer

      Hormone that keeps us alert also suppresses the spread of cancer

      "Since the steroid levels peak during waking hours and drop off during sleep, the scientists asked how this might affect the second receptor - EGFR. Checking the levels of this activity in mice, they found that there was a significant difference: This receptor is much more active during sleep and quiescent during waking hours. 

      The conclusion, say the scientists, is that it could be more efficient to administer certain anticancer drugs at night."

      Read Full Article
    8. Memorial Sloan Kettering Doctors’ Stance on the High Cost of Cancer Drugs Featured on 60 Minutes

      Memorial Sloan Kettering Doctors’ Stance on the High Cost of Cancer Drugs Featured on 60 Minutes

      “A cancer diagnosis is one of the leading causes of personal bankruptcy,” Dr. Saltz said in the 60 Minutes piece. Dr. Bach added that “we need to take into account the financial consequences of the decisions that we make for our patients” as each new cancer drug that comes to market costs more than the last, and the burden of that cost is borne increasingly by patients."

      Read Full Article
    9. BSD Announces the Opening of the Center for Treatment of Children with Hyperthermia and Chemotherapy at Charité UMS

      SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that the Charité Universitätsmedizin Berlin (Charité), Department of Pediatric Hematology and Oncology, in cooperation with the Charité Department of Radiation Oncology, has opened a center dedicated to the treatment of pediatric tumors using hyperthermia and chemotherapy. Prof. Angelika Eggert MD, Chair of the Department of Pediatric Hematology and Oncology as well as President of th

      Read Full Article
      Mentions: Treatment
    10. ImmunoCellular Therapeutics Expands Cancer Immunotherapy Platform with Antigen-Specific T-cell Technology Licensed from Caltech

      LOS ANGELES, Sept. 24, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) announced today that it has established a licensing agreement with the California Institute of Technology (Caltech) for exclusive rights to novel technology for the...

      Read Full Article
      Mentions: Immunotherapy
    11. Finding Risks, Not Answers, in Gene Tests

      Finding Risks, Not Answers, in Gene Tests

      Jennifer was 39 and perfectly healthy, but her grandmother had died young from breast cancer, so she decided to be tested for mutations in two genes known to increase risk for the disease.

      When a genetic counselor offered additional tests for 20 other genes linked to various cancers, Jennifer said yes. The more information, the better, she thought.

      The results, she said, were “surreal.” She did not have mutations in the breast cancer genes, but did have one linked to a high risk of stomach cancer. In people with a family history of the disease, that mutation is considered so ...

      Read Full Article
    121-144 of 185 « 1 2 3 4 5 6 7 8 »
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Popular Articles